Patents by Inventor Terry Y. Chow

Terry Y. Chow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF ALPHA-2-MACROGLOBULIN FOR DETERMINING OSTEONECROSIS DISEASE STATUS AND FOR SCREENING THERAPEUTIC AGENTS FOR PREVENTING OR TREATING OSTEONECROSIS
    Publication number: 20130345073
    Abstract: The present application presents a method of assessing a predisposition to osteonecrosis in an individual based on the level of expression/activity of alpha-2-macroglubulin, a biomarker whose expression is positively correlated with osteonecrosis. Also provided herein are a diagnostic/prognostic system as well as a software product based on the determination of the level of expression/activity of alpha-2-macroglobulin. Screening methods for the determination of usefulness of an agent in the prevention and/or treatment of osteonecrosis are also provided.
    Type: Application
    Filed: June 22, 2012
    Publication date: December 26, 2013
    Inventors: Chantal Séguin, Edward Harvey, Denis Cournoyer, Terry Y. Chow, Mohammad Amin Kerachian
  • Enhanced production of biosurfactant through the use of a mutated B subtilis strain
    Patent number: 5037758
    Abstract: A B. subtilis strain possessing an enhanced surfactin production potential. The strain is a mutant of B. subtilis ATCC 21332 and has at least one mutation between Arg4 and HisA1 sites of the genetic map of B. subtilis ATCC 21332. Also included in the present invention is B. subtilis strain having the identifying characteristics of ATCC 53813.
    Type: Grant
    Filed: January 11, 1989
    Date of Patent: August 6, 1991
    Assignee: Her Majesty the Queen in right of Canada, as represented by the National Research Council of Canada
    Inventors: Catherine N. Mulligan, Terry Y. Chow